Literature DB >> 9345285

The role of CD8+ Th2 lymphocytes in the development of smoking-related lung damage.

S Mattoli1, J Kleimberg, M A Stacey, A Bellini, G Sun, M Marini.   

Abstract

There is increasing evidence for the existence of different subsets of CD8+ T lymphocytes in humans, according to their cytokine secretion profile. Resistance or susceptibility to infections and the outcome of some inflammatory processes may depend on the lymphokine profile which predominates. We show one consequence of the switching of a host CD8+ T cell response from the Th1 effector function to the Th2 pattern in relation to the exposure to a common toxicant and its pathogenetic implications. Chronic obstructive bronchitis is a pulmonary disease characterized by airway inflammation with predominance of CD8+ T lymphocytes, mucus hypersecretion, repeated airway infections, and decline in lung function. Though smoking-related, it affects only a portion of smokers. The results of this study, comparing the functional characteristics of CD8+ T cell clones from smokers with the disease, unaffected smokers and healthy individuals, indicate that the smokers who have a predominance of CD8+ T lymphocytes of the Th2 phenotype may be predisposed to develop more severe smoking-induced lung damage, with chronic airway inflammation, repeated infections and persistent airflow obstruction.

Entities:  

Mesh:

Year:  1997        PMID: 9345285     DOI: 10.1006/bbrc.1997.7444

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease.

Authors:  B Barceló; J Pons; A Fuster; J Sauleda; A Noguera; J M Ferrer; A G N Agustí
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

2.  Sarcoid-Like Granulomatous Disease: Pathologic Case Series in World Trade Center Dust Exposed Rescue and Recovery Workers.

Authors:  Vasanthi R Sunil; Jared Radbel; Sabiha Hussain; Kinal N Vayas; Jessica Cervelli; Malik Deen; Howard Kipen; Iris Udasin; Robert Laumbach; Jag Sunderram; Jeffrey D Laskin; Debra L Laskin
Journal:  Int J Environ Res Public Health       Date:  2019-03-06       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.